Contract Services Contract Manufacturing
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (C...
November 08, 2022 | News
Polyplus and ENcell sign MOU for gene therapy discovery and optimization projects in Korea
“ENCell is working to accelerate viral vector CMO business via a collaboration with Polyplus.”, said Dr. Jong Wook Chang, CEO of ENCell. &ldquo...
October 28, 2022 | News
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet...
October 28, 2022 | News
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
New research from the CPHI Annual Report 2022 – launched during CPHI Frankfurt (1-3 November, 2022) – predicts that huge volumes of V...
October 28, 2022 | News
Samsung Biologics Reports Third Quarter 2022 Financial Results
Recorded consolidated revenue of KRW 873 billion in Q3'22 Recorded consolidated operating profit of KRW 324.7 billion in Q3'...
October 27, 2022 | News
WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China
The facility's design incorporates environmental protection, energy conservation, emission reduction, and resource utilization – a reflection of WuXi...
October 26, 2022 | News
WuXi Biologics adds further capacity and capability for drug product fill & finish
WuXi Biologics to provide global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP. WuXi Biologics ("WuXi Bio"...
October 24, 2022 | News
CPHI Annual Report predicts growth for biologics manufacturing and CMOs in 2023
CPHI Frankfurt Report predicts ‘biologics outsourcing to surge in 2023, as China’s innovation engine stalls’ Ahead of the world’s ...
October 21, 2022 | News
GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft
GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and GeneCraft (Suk Chul Bae, CEO), a global research team led by Professor Suk Ch...
October 18, 2022 | News
Samsung Biologics obtains three global ISO certifications
Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems F...
October 14, 2022 | News
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000...
October 12, 2022 | News
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody
Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...
October 12, 2022 | News
Vetter drives its sustainability campaign forward
Repeat participation in Baden Wuerttemberg’s Sustainability Days Greater inclusion of employees due to involvement in various initiatives Awards ...
October 11, 2022 | News
Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services
New 2,700-square-meter facility expands production capacity for monoclonal antibodies (mAbs) and other recombinant proteins Clients benefit from differe...
October 05, 2022 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
